Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Capsugel Expands Global Manufacturing for Finished Dosage Forms

Published: Thursday, September 26, 2013
Last Updated: Thursday, September 26, 2013
Bookmark and Share
DFS unit expands capabilities for hormonal, high-potency compounds.

Capsugel’s Dosage Form Solutions (DFS) business unit has unveiled extensive upgrades and expansions to three of its manufacturing facilities in the United States and Europe, deepening the company’s finished dosage form capabilities as part of its LIPIDEX® technology platform.

The multi-million dollar investments broaden the company’s global capabilities to handle hormonal as well as high potent compounds for soft gelatin and liquid-fill hard capsules (LFHC), responding to a growing demand from its pharmaceutical and health and nutrition customers.

“Investments at our soft gelatin and LFHC facilities reinforce Capsugel’s leadership in liquid-fill technologies and our commitment to offering customers a comprehensive range of services from formulation development to commercial manufacturing. Backed by decades of capsule engineering, specialized formulation know-how and global supply chain expertise, customers can be assured of high quality encapsulated products using SGcaps® and Licaps® technology,” said Anthony Macci, SVP of Global Operations.

Macci continued, “Our continued expansion and integration of our product development and manufacturing capabilities further ensures that customer projects find optimized solutions, fast.”

Investment highlights include:

• Ploermel facility in France: Increased containment capacity to handle hormonal as well as high-potent compounds in softgel manufacturing at this FDA-inspected and MHRA/ANVISA-accredited site. Specific upgrades include a new, high precision dosing system and high-speed capsule printing capability.

• Livingston facility in the UK: Expanded with additional laboratory space, equipment and analytical scientists at this FDA/MHRA-accredited site. The latest generation CFS 1500 capsule filling and sealing machine, which incorporates proprietary Fusion technology, has been installed, and the proprietary lipid expert system has been incorporated into the team’s finished dosage form development process.

• Greenwood facility in the U.S.: Commissioned and validated a new commercial scale liquid-fill encapsulation unit for pharmaceutical applications. The installation of commercial production capability for the new solid lipid pellet (SLP) technology has also been initiated. SLP technology is currently being used on select customer development projects as a unique lipid-based formulation option for bioenhancement and other formulation issues.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Capsugel Completes Acquisitions of Xcelience and Powdersize
Acquisitions provide Capsugel with specialized clinical trial manufacturing and supply capabilities.
Thursday, January 07, 2016
Capsugel to Acquire Xcelience and Powdersize
Xcelience provides the company with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms.
Thursday, December 17, 2015
Capsugel Expanding Pharmaceutical Product Development and Manufacturing Capabilities
Investment accommodates the company’s growing pipeline of pharmaceutical customer projects and brings a broader range of technologies closer to its European customers.
Thursday, August 06, 2015
Capsugel Unveils New Spray-Dried Dispersion Commercial Manufacturing Facility
Significantly expands the commercial manufacturing capability at its Bend, Ore. Site.
Thursday, July 02, 2015
Capsugel Extends Inhaled Biotherapeutics Delivery Capability to Phase 2 Clinical Trials
Company partnering with customers to expand the use of inhalation technologies to treat a wider range of diseases.
Thursday, May 07, 2015
Capsugel Awarded EXCiPACT™ Certifications
First hard capsule manufacturer to receive this important third-party recognition.
Wednesday, October 08, 2014
Capsugel and Cardax to Collaborate on Astaxanthin Products Development
Collaboration leverages Capsugel’s proprietary lipid-based technologies for potential development of consumer health products.
Thursday, August 21, 2014
Capsugel to Acquire Bend Research
Enhances bioavailability expertise.
Thursday, September 12, 2013
Capsugel Unveils Quality Control Laboratory
South Carolina based facility provides global center of excellence for the company.
Monday, December 10, 2012
Scientific News
Microdroplet Reactors Mimic Living Systems
Researchers use microdroplets to study non-equilibrium reactions like those in living organisms.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!